Navigation Links
3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
Date:7/10/2012

MENLO PARK, Calif., July 10, 2012 /PRNewswire/ -- 3-V Biosciences, Inc., announced today that George Kemble, PhD, Chief Scientific Officer, will present at the upcoming JMP Securities Healthcare Conference at the Peninsula Hotel in New York City.  Dr. Kemble will provide an overview of 3-V, including a discussion of both its lead program targeting the fatty acid synthase (FASN) pathway for the treatment of chronic hepatitis C virus (HCV) infection and the company's discovery platform.  Dr. Kemble's presentation will take place on Friday, July 13 at 12:00pm.

FASN is a cellular enzyme with increased expression following infection with HCV and in several cancers.  First-generation FASN inhibitors have shown preclinical benefits in a variety of viral infections, including HCV, as well as in models of pancreatic, prostatic, breast and colorectal tumors, but their development has been hindered by poor bioavailability and systemic tolerability.  3-V has discovered and is advancing proprietary FASN inhibitors with pharmaceutical properties that overcome the shortcomings of earlier generations of inhibitors, and have the potential to become potent therapeutics for chronic HCV and other indications.

About 3-V Biosciences

3-V Biosciences, Inc. is a privately held biopharmaceutical company that discovers and develops antiviral therapeutics designed to have broad-spectrum activity, including efficacy against viruses resistant to other classes of antiviral drugs, and a high barrier to resistance.  The 3-V team applies an integrated approach with internal expertise in virology, biology, drug discovery and development to drive programs forward.  The company is located in Menlo Park, California.

For additional information on 3-V Biosciences, please visit www.3vbio.com.

Contact information Stephen R. Brady Chief Business Officer 650-561-8600


'/>"/>
SOURCE 3-V Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
2. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
3. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
4. Neurocrine Biosciences Reports First Quarter 2012 Results
5. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
7. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
8. Insmed To Present At JMP Securities 7th Annual Healthcare Conference
9. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
10. Anthera Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
11. Delcath To Present At JMP Securities Healthcare Conference On July 12
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2019)... ... 08, 2019 , ... A new study from researchers at the UConn Rudd ... overwhelmingly engage with fast food, unhealthy snacks, candy and soft drinks filled with sugar. ... get stuck inside with family members visiting from out of town. But a ...
(Date:12/6/2019)... ... December 06, 2019 , ... Food and nutrition ... information and ideas about working toward sustainable nutrition security nationwide, increasing accessibility to ... we develop a healthy and sustainable food system,” said Carol May, CEO of ...
(Date:12/5/2019)... SAN FRANCISCO (PRWEB) , ... December 05, 2019 ... ... senior-level biopharma leaders through off-the-record collaboration and dialogue, today announces key issues to ... 11-12, 2020 at the Four Seasons Hotel in San Francisco. ...
Breaking Medicine Technology:
(Date:12/9/2019)... ... ... OCLI, a Spectrum Vision Partners (SVP) managed practice, has announced the addition ... practice with experience spanning decades. As part of OCLI, Drs. Cary Silverman, Nicholas Xanthos ... 46 Eagle Rock Ave, East Hanover, NJ 07936. , Over the past ...
(Date:12/8/2019)... ... December 08, 2019 , ... Intelligent.com, ... the Top 52 Best Homeland Security Degree Programs for 2020. The comprehensive research ... the nation. Each program is evaluated based on curriculum quality, graduation rate, reputation, ...
(Date:12/6/2019)... ... , ... Allegheny Health Network (AHN) has named Kymberly Gyure, MD, Chair of ... in May 2018, previously served as AHN’s Vice Chair of Pathology and Laboratory Medicine, ... is also part of the pathology faculty at Drexel University College of Medicine. ...
(Date:12/6/2019)... Calif. (PRWEB) , ... December 06, 2019 , ... Dr. ... Sciences program, recently published research on the health benefits of coconut oil in ... Oil Intake and Its Effects on the Cardiometabolic Profile: A Structured Literature Review,” led ...
(Date:12/5/2019)... GILBERT, Ariz. (PRWEB) , ... December 05, 2019 ... ... International , with milestones ranging from launching exceptional products that help people embrace, ... around the world. , “We’ve never been more committed to our mission of ...
Breaking Medicine News(10 mins):